Displaying drugs 14751 - 14775 of 14910 in total
3-(N-morpholino)propanesulfonic acid
Experimental
Ghavamiol
Experimental
4-Methyl-5-Hydroxyethylthiazole Phosphate
Experimental
5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone
Experimental
1-Methyl-2-Oxy-5,5-Dimethyl Pyrrolidine
Experimental
Methyl pyrrolidone
N Methyl Pyrrolidone is under investigation for the treatment of Multiple Myeloma.
Investigational
ETC-1001
ETC-1001 is Pfizer’s lead oral small molecule product candidate which is intended to be a chronic treatment for individuals with lipid disorders.
Investigational
Denibulin
Denibulin is a novel small molecule Vascular Disrupting Agent under development by MediciNova for treatment of solid tumor cancers.
Investigational
3-Decyl-2,5-Dioxo-4-Hydroxy-3-Pyrroline
Experimental
AL5300
Experimental
N-(2-Thienylmethyl)-2,5-Thiophenedisulfonamide
Experimental
4-Methylpiperazin-1-Yl Carbonyl Group
Experimental
AEOL-10150
AEOL 10150 is developed by Aeolus as a therapeutic agents based on its proprietary small molecule catalytic antioxidants.
Investigational
CP-744809
Experimental
Morinamide
Experimental
Displaying drugs 14751 - 14775 of 14910 in total